Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

ClinicalTrials.gov ID: NCT00003809

Public ClinicalTrials.gov record NCT00003809. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double Blind, Placebo Controlled Phase III Evaluation of Cisplatin + Placebo Versus Cisplatin + C225 a Mouse/Human Monoclonal Antibody to the Epidermal Growth Factor Receptor, in Patients With Metastatic and/or Recurrent Squamous Cell Cancer of the Head and Neck

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Monoclonal antibodies can locate cancer cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether cisplatin plus monoclonal antibody therapy is more effective than cisplatin alone for metastatic or recurrent head and neck cancer. PURPOSE: Randomized double-blinded phase III trial to compare the effectiveness of cisplatin with or without monoclonal antibody in treating patients who have metastatic or recurrent head and neck cancer.

Study identification

NCT ID
NCT00003809
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
Not listed

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 6, 1999 (Actual)
Primary completion
Sep 2004 (Actual)
Completion
Not listed
Last update posted
Feb 27, 2026

Started 1999

United States locations

U.S. sites
73
U.S. states
28
U.S. cities
57
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404 —
Mayo Clinic Scottsdale Scottsdale Arizona 85259 —
Beckman Research Institute, City of Hope Los Angeles California 91010 —
Veterans Affairs Medical Center - Palo Alto Palo Alto California 94304 —
Stanford University Medical Center Stanford California 94305-5408 —
CCOP - Colorado Cancer Research Program, Inc. Denver Colorado 80209-5031 —
Yale Comprehensive Cancer Center New Haven Connecticut 06520-8028 —
CCOP - Christiana Care Health Services Wilmington Delaware 19899 —
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5000 —
Veterans Affairs Medical Center - Gainsville Gainesville Florida 32608-1197 —
Sylvester Cancer Center, University of Miami Miami Florida 33136 —
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 —
Veterans Affairs Medical Center - Tampa (Haley) Tampa Florida 33612 —
Emory University Hospital - Atlanta Atlanta Georgia 30322 —
Veterans Affairs Medical Center - Atlanta (Decatur) Decatur Georgia 30033 —
Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago Illinois 60611 —
Veterans Affairs Medical Center - Lakeside Chicago Chicago Illinois 60611 —
CCOP - Central Illinois Decatur Illinois 62526 —
CCOP - Evanston Evanston Illinois 60201 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61602 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
Indiana University Cancer Center Indianapolis Indiana 46202-5265 —
Veterans Affairs Medical Center - Indianapolis (Roudebush) Indianapolis Indiana 46202 —
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206 —
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016 —
CCOP - Wichita Wichita Kansas 67214-3882 —
MBCCOP - LSU Medical Center New Orleans Louisiana 70112 —
CCOP - Ochsner New Orleans Louisiana 70121 —
Johns Hopkins Oncology Center Baltimore Maryland 21231 —
New England Medical Center Hospital Boston Massachusetts 02111 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
CCOP - Ann Arbor Regional Ann Arbor Michigan 48106 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
CCOP - Duluth Duluth Minnesota 55805 —
Veterans Affairs Medical Center - Minneapolis Minneapolis Minnesota 55417 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131 —
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
CCOP - Northern New Jersey Hackensack New Jersey 07601 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Cancer Institute of New Jersey New Brunswick New Jersey 08901 —
Riverview Medical Center Red Bank New Jersey 07701 —
St. Francis Medical Center Trenton New Jersey 08629 —
Veterans Affairs Medical Center - Albany Albany New York 12208 —
Veterans Affairs Medical Center - Brooklyn Brooklyn New York 11209 —
Veterans Affairs Medical Center - New York New York New York 10010 —
NYU School of Medicine's Kaplan Comprehensive Cancer Center New York New York 10016 —
University of Rochester Cancer Center Rochester New York 14642 —
Albert Einstein Comprehensive Cancer Center The Bronx New York 10461 —
CCOP - Merit Care Hospital Fargo North Dakota 58122 —
Ireland Cancer Center Cleveland Ohio 44106-5065 —
Veterans Affairs Medical Center - Cleveland Cleveland Ohio 44106 —
CCOP - Columbus Columbus Ohio 43206 —
CCOP - Toledo Community Hospital Oncology Program Toledo Ohio 43623-3456 —
CCOP - Sooner State Tulsa Oklahoma 74136 —
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001 —
Penn State Geisinger Cancer Center Hershey Pennsylvania 17033 —
Hahnemann University Hospital Philadelphia Pennsylvania 19102-1192 —
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104 —
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania 19107 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15213 —
Veterans Affairs Medical Center - Pittsburgh Pittsburgh Pennsylvania 15240 —
CCOP - MainLine Health Wynnewood Pennsylvania 19096 —
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57105-1080 —
Veterans Affairs Medical Center - Nashville Nashville Tennessee 37212 —
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838 —
Veterans Affairs Medical Center - Madison Madison Wisconsin 53705 —
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792 —
CCOP - Marshfield Medical Research and Education Foundation Marshfield Wisconsin 54449 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —
Veterans Affairs Medical Center - Milwaukee (Zablocki) Milwaukee Wisconsin 53295 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003809, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00003809 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →